For TB patients with CD4+ T cell counts lower than 200 cells/ mm3, the effects of cART on survival are convincing, [7–10] but for patients with CD4+ T cell counts above 350 cells/mm3, the effects of cART on survival are conflicting [11]. This evidence concerns the gene CD4 and tuberculosis.